Page 2 - 595 6 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vote on the fda's recommendations today. joining us now to discuss, dr. lena wen, cnn medical analyst and emergency physician and former baltimore city health commissioner. good to have you back. it seems to me when you look at the data across the board, pfizer showing remarkable efficacy, 95.6%. you have approval for boosters for moderna and johnson & johnson shots and you have the ability to mix and match as it is called to take one vaccination and boost with another brand of vaccine. big picture, is that good news? right? it gives us all options going forward. >> i think it is great news. i...

From pfizer show a booster dose of the company's vaccine is 95.6% effective. meanwhile the cdc says more people are getting booster doses than are getting their first dose convincing more of the 64 million people who are eligible for a shot but haven't gotten one to get one will be key to slowing covid's spread. key to slowing covid spread, vaccinating some 28 million children ages 5 to 11 some of whom have suffered gravely from the virus. >> fundamentally we've seen over the last 18 months that covid has not been benign among children even though they do better than older adults. we've had hu...

Shots. one thing i just want to say quickly, the vast majority of severe illness, hospitalization and death is still very much among the unvaccinated. boosters are important, but when we talk about the next few months, this is an unvaccinated problem primarily. >> i'm glad you made that point. the data is so clear. just one more question on boosters as we move in that direction. pfizer announced its data really just off the charts. 95.6% efficacy against covid, this in a phase three trial. what's the significance of that? >> yeah. i think what this is showing basically is when they got this bo...

Try it for free. visit freestylelibre.us now to other stories this thursday. the fda authorized booster shots of the moderna and j&j vaccines, also approving a mix and match approach to boosters, those eligible could get a booster shot from a different vaccine maker from the vaccine they initially received. pfizer says its booster is 95.6% fktive against covid-19 in phase three trials. across the pond uk its highest number of cases since july, a 60% jump. officials point out two-thirds of adults are fully vaccinated, dramatically reducing the risk of hospitalization and death. senator klob...

Pfizer has just announced booster doses of its vaccine show a 95.6% efficacy against covid-19. the company says that number was consistent regardless of age, gender, race, ethnicity or pre-existing conditions. co-morbidities. this also comes as the fda has authorized booster shots of both moderna and johnson & johnson's vaccines. and also saying that mix and match approach for boosters is fine. >> yeah. >> today's currently available data suggests waning immunity in some populations of fully vaccinated people. and the availability of these boosters is important for continued protection against...